Codexis (CDXS) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Codexis Revenue Highlights


Latest Revenue (Y)

$70.14M

Latest Revenue (Q)

$12.83M

Main Segment (Y)

Enzyme Product

Main Geography (Y)

Asia Pacific

Codexis Revenue by Period


Codexis Revenue by Year

DateRevenueChange
2023-12-31$70.14M-49.39%
2022-12-31$138.59M32.30%
2021-12-31$104.75M51.69%
2020-12-31$69.06M0.87%
2019-12-31$68.46M12.98%
2018-12-31$60.59M21.13%
2017-12-31$50.02M2.43%
2016-12-31$48.84M16.82%
2015-12-31$41.80M18.40%
2014-12-31$35.31M10.60%
2013-12-31$31.92M-63.85%
2012-12-31$88.30M-28.71%
2011-12-31$123.86M15.65%
2010-12-31$107.10M29.18%
2009-12-31$82.91M64.25%
2008-12-31$50.48M99.26%
2007-12-31$25.33M108.90%
2006-12-31$12.13M-

Codexis generated $70.14M in revenue during NA 2023, up -49.39% compared to the previous quarter, and up 115.76% compared to the same period a year ago.

Codexis Revenue by Quarter

DateRevenueChange
2024-09-30$12.83M60.83%
2024-06-30$7.98M-53.27%
2024-03-31$17.07M-35.72%
2023-12-31$26.56M186.31%
2023-09-30$9.28M-56.49%
2023-06-30$21.32M64.25%
2023-03-31$12.98M-57.26%
2022-12-31$30.38M-11.88%
2022-09-30$34.47M-10.25%
2022-06-30$38.41M8.68%
2022-03-31$35.34M44.24%
2021-12-31$24.50M-33.37%
2021-09-30$36.77M44.46%
2021-06-30$25.45M41.15%
2021-03-31$18.03M-14.27%
2020-12-31$21.03M14.41%
2020-09-30$18.39M22.84%
2020-06-30$14.97M2.02%
2020-03-31$14.67M-21.34%
2019-12-31$18.65M-14.86%
2019-09-30$21.91M77.82%
2019-06-30$12.32M-20.95%
2019-03-31$15.58M-3.02%
2018-12-31$16.07M-5.18%
2018-09-30$16.95M25.17%
2018-06-30$13.54M-3.59%
2018-03-31$14.04M-35.36%
2017-12-31$21.72M117.57%
2017-09-30$9.98M-3.51%
2017-06-30$10.35M29.81%
2017-03-31$7.97M-20.04%
2016-12-31$9.97M-32.96%
2016-09-30$14.87M-7.07%
2016-06-30$16.00M100.13%
2016-03-31$8.00M-30.99%
2015-12-31$11.59M-33.42%
2015-09-30$17.40M189.15%
2015-06-30$6.02M-11.47%
2015-03-31$6.80M-52.10%
2014-12-31$14.19M89.92%
2014-09-30$7.47M13.73%
2014-06-30$6.57M-7.12%
2014-03-31$7.07M-25.73%
2013-12-31$9.53M141.57%
2013-09-30$3.94M-43.46%
2013-06-30$6.97M-39.26%
2013-03-31$11.48M45.11%
2012-12-31$7.91M-69.96%
2012-09-30$26.34M14.98%
2012-06-30$22.91M-26.42%
2012-03-31$31.14M-7.04%
2011-12-31$33.49M0.63%
2011-09-30$33.28M27.74%
2011-06-30$26.05M-16.04%
2011-03-31$31.03M4.10%
2010-12-31$29.81M9.95%
2010-09-30$27.11M10.76%
2010-06-30$24.48M-4.75%
2010-03-31$25.70M6.03%
2009-12-31$24.24M20.82%
2009-09-30$20.06M4.50%
2009-06-30$19.20M-1.09%
2009-03-31$19.41M4.37%
2008-12-31$18.60M122.09%
2008-03-31$8.37M78.02%
2007-03-31$4.70M-

Codexis generated $12.83M in revenue during Q3 2024, up 60.83% compared to the previous quarter, and up 60.18% compared to the same period a year ago.

Codexis Revenue Breakdown


Codexis Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 22Dec 21Dec 20Dec 19Dec 18
Enzyme Product$75.40M$1.70M---
Product Sales$29.00M$3.28M$2.49M$1.99M$2.20M
Research and Development Revenue$1.61M$3.05M$2.30M$57.00K$2.73M
Sitagliptin Enzyme$1.60M$2.80M---
Service-$34.10M$38.84M$38.99M$35.00M

Codexis's latest annual revenue breakdown by segment (product or service), as of Dec 22: Enzyme Product (70.07%), Product Sales (26.95%), Research and Development Revenue (1.50%), and Sitagliptin Enzyme (1.49%).

Quarterly Revenue by Product

Product/ServiceSep 24Mar 24Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19
Product$11.16M$18.68M$19.10M$8.37M$3.60M$2.50M--------------
Research and Development Revenue$1.68M$3.88M$1.54M$7.50M$7.08M$1.47M$2.33M$2.10M$7.52M$3.36M$3.50M$1.98M$8.82M$2.07M$2.21M$6.48M$13.77M$1.29M$5.57M-
Product Sales-$10.49M$21.38M$3.05M$2.97M$16.98M$2.84M$1.98M$2.82M$12.21M$1.99M$2.83M$2.05M$4.88M------
Research And Development Revenue-$7.52M------------------
Enzyme Product-----$19.80M--------------

Codexis's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Product (86.95%), and Research and Development Revenue (13.05%).

Codexis Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 22Dec 21Dec 20Dec 19Dec 18
EMEA$56.54M$20.19M$19.26M$37.13M$22.36M
Americas$17.00M$23.48M$24.35M$13.04M$15.37M
Asia Pacific$65.05M$61.09M---
APAC--$25.45M$18.29M$22.86M

Codexis's latest annual revenue breakdown by geography, as of Dec 22: Asia Pacific (46.94%), EMEA (40.80%), and Americas (12.27%).

Quarterly Revenue by Country

CountrySep 24Mar 24Sep 23Dec 21Sep 21Dec 19Jun 18Mar 18
APAC$9.07M$7.26M$1.81M$2.77M----
Americas$1.53M$7.24M$4.28M$3.42M----
EMEA$2.23M$2.57M$3.19M$12.46M$1.44M$1.68M--
Asia Pacific---$16.56M$24.27M---

Codexis's latest quarterly revenue breakdown by geography, as of Sep 24: APAC (70.68%), EMEA (17.37%), and Americas (11.95%).

Codexis Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
KYMRKymera Therapeutics$78.59M$3.74M
NRIXNurix Therapeutics$76.99M$12.59M
CDXSCodexis$70.14M$12.83M
FHTXFoghorn Therapeutics$34.16M$7.81M
RVMDRevolution Medicines$11.58M-
KZRKezar Life Sciences$7.00M-
GBIOGeneration Bio$5.90M$4.09M
IPSCCentury Therapeutics$2.23M$791.00K
STTKShattuck Labs$1.66M$1.61M
LYELLyell Immunopharma$130.00K$34.00K
CGEMCullinan Oncology--
NKTXNkarta--
MLYSMineralys Therapeutics--
GLUEMonte Rosa Therapeutics-$4.70M
NUVBNuvation Bio-$727.00K

CDXS Revenue FAQ


What is Codexis’s yearly revenue?

Codexis's yearly revenue for 2023 was $70.14M, representing a decrease of -49.39% compared to 2022. The company's yearly revenue for 2022 was $138.59M, representing an increase of 32.30% compared to 2021. CDXS's yearly revenue for 2021 was $104.75M, representing an increase of 51.69% compared to 2020.

What is Codexis’s quarterly revenue?

Codexis's quarterly revenue for Q3 2024 was $12.83M, a 60.83% increase from the previous quarter (Q2 2024), and a 38.33% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $7.98M, a -53.27% decrease from the previous quarter (Q1 2024), and a -62.58% decrease year-over-year (Q2 2023). CDXS's quarterly revenue for Q1 2024 was $17.07M, a -35.72% decrease from the previous quarter (Q4 2023), and a 31.51% increase year-over-year (Q1 2023).

What is Codexis’s revenue growth rate?

Codexis's revenue growth rate for the last 3 years (2021-2023) was -33.04%, and for the last 5 years (2019-2023) was 2.46%.

What are Codexis’s revenue streams?

Codexis's revenue streams in c 22 are Enzyme Product, Product Sales, Research and Development Revenue, and Sitagliptin Enzyme. Enzyme Product generated $75.4M in revenue, accounting 70.07% of the company's total revenue, up 4335.29% year-over-year. Product Sales generated $29M in revenue, accounting 26.95% of the company's total revenue, up 783.75% year-over-year. Research and Development Revenue generated $1.61M in revenue, accounting 1.50% of the company's total revenue, down -47.18% year-over-year. Sitagliptin Enzyme generated $1.6M in revenue, accounting 1.49% of the company's total revenue, down -42.86% year-over-year.

What is Codexis’s main source of revenue?

For the fiscal year ending Dec 22, the largest source of revenue of Codexis was Enzyme Product. This segment made a revenue of $75.4M, representing 70.07% of the company's total revenue.